BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25599326)

  • 1. The status of contemporary image-guided modalities in oncologic surgery.
    Rosenthal EL; Warram JM; Bland KI; Zinn KR
    Ann Surg; 2015 Jan; 261(1):46-55. PubMed ID: 25599326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical innovations in surgery.
    de Boer E; Harlaar NJ; Taruttis A; Nagengast WB; Rosenthal EL; Ntziachristos V; van Dam GM
    Br J Surg; 2015 Jan; 102(2):e56-72. PubMed ID: 25627136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical image-guided cancer surgery: challenges and limitations.
    Keereweer S; Van Driel PB; Snoeks TJ; Kerrebijn JD; Baatenburg de Jong RJ; Vahrmeijer AL; Sterenborg HJ; Löwik CW
    Clin Cancer Res; 2013 Jul; 19(14):3745-54. PubMed ID: 23674494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers.
    Greco F; Cadeddu JA; Gill IS; Kaouk JH; Remzi M; Thompson RH; van Leeuwen FW; van der Poel HG; Fornara P; Rassweiler J
    Eur Urol; 2014 May; 65(5):947-64. PubMed ID: 23957947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovations in Intraoperative Tumor Visualization.
    Visgauss JD; Eward WC; Brigman BE
    Orthop Clin North Am; 2016 Jan; 47(1):253-64. PubMed ID: 26614939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-Time Imaging of Brain Tumor for Image-Guided Surgery.
    Hu S; Kang H; Baek Y; El Fakhri G; Kuang A; Choi HS
    Adv Healthc Mater; 2018 Aug; 7(16):e1800066. PubMed ID: 29719137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies.
    Bortot B; Mangogna A; Di Lorenzo G; Stabile G; Ricci G; Biffi S
    J Nanobiotechnology; 2023 May; 21(1):155. PubMed ID: 37202750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies.
    Li Y; Rey-Dios R; Roberts DW; Valdés PA; Cohen-Gadol AA
    World Neurosurg; 2014; 82(1-2):175-85. PubMed ID: 23851210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An initial report on the intraoperative use of indocyanine green fluorescence imaging in the surgical management of liver tumorss.
    Takahashi H; Zaidi N; Berber E
    J Surg Oncol; 2016 Oct; 114(5):625-629. PubMed ID: 27611115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
    Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
    World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic Procedures Amenable to Fluorescence-guided Surgery.
    Tipirneni KE; Warram JM; Moore LS; Prince AC; de Boer E; Jani AH; Wapnir IL; Liao JC; Bouvet M; Behnke NK; Hawn MT; Poultsides GA; Vahrmeijer AL; Carroll WR; Zinn KR; Rosenthal E
    Ann Surg; 2017 Jul; 266(1):36-47. PubMed ID: 28045715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
    Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
    J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An operational near-infrared fluorescence imaging system prototype for large animal surgery.
    De Grand AM; Frangioni JV
    Technol Cancer Res Treat; 2003 Dec; 2(6):553-62. PubMed ID: 14640766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.
    Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS
    J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative fluorescent imaging of intracranial tumors: a review.
    Behbahaninia M; Martirosyan NL; Georges J; Udovich JA; Kalani MY; Feuerstein BG; Nakaji P; Spetzler RF; Preul MC
    Clin Neurol Neurosurg; 2013 May; 115(5):517-28. PubMed ID: 23523009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
    Rapp M; Kamp M; Steiger HJ; Sabel M
    World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.
    Schucht P; Beck J; Abu-Isa J; Andereggen L; Murek M; Seidel K; Stieglitz L; Raabe A
    Neurosurgery; 2012 Nov; 71(5):927-35; discussion 935-6. PubMed ID: 22895402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence-guided cancer surgery-A new paradigm.
    Thammineedi SR; Saksena AR; Nusrath S; Iyer RR; Shukla S; Patnaik SC; Reddy RP; Boleneni N; Sharma RM; Smith L; Are C
    J Surg Oncol; 2021 May; 123(8):1679-1698. PubMed ID: 33765329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
    Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
    Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.